Future scenarios for the SARS-CoV-2 epidemic in Switzerland: an age-structured model.


Journal

F1000Research
ISSN: 2046-1402
Titre abrégé: F1000Res
Pays: England
ID NLM: 101594320

Informations de publication

Date de publication:
2020
Historique:
accepted: 09 12 2020
entrez: 12 10 2021
pubmed: 25 6 2020
medline: 14 10 2021
Statut: epublish

Résumé

The recent lifting of COVID-19 related restrictions in Switzerland causes uncertainty about the future of the epidemic. We developed a compartmental model for SARS-CoV-2 transmission in Switzerland and projected the course of the epidemic until the end of year 2020 under various scenarios. The model was age-structured with three categories: children (0-17), adults (18-64) and seniors (65- years). Lifting all restrictions according to the plans disclosed by the Swiss federal authorities by mid-May resulted in a rapid rebound in the epidemic, with the peak expected in July. Measures equivalent to at least 76% reduction in all contacts were able to eradicate the epidemic; a 54% reduction in contacts could keep the intensive care unit occupancy under the critical level and delay the next wave until October. In scenarios where strong contact reductions were only applied in selected age groups, the epidemic could not be suppressed, resulting in an increased risk of a rebound in July, and another stronger wave in September. Future interventions need to cover all age groups to keep the SARS-CoV-2 epidemic under control.

Identifiants

pubmed: 34631035
doi: 10.12688/f1000research.24497.2
pmc: PMC8477351
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

646

Informations de copyright

Copyright: © 2021 Estill J et al.

Déclaration de conflit d'intérêts

No competing interests were disclosed.

Références

BMC Med. 2020 Jul 30;18(1):240
pubmed: 32727547
CMAJ. 2020 May 25;192(21):E566-E573
pubmed: 32385067
Nature. 2020 Aug;584(7820):257-261
pubmed: 32512579
Math Biosci. 2002 Sep-Oct;179(2):207-17
pubmed: 12208616
Int J Infect Dis. 2020 Apr;93:284-286
pubmed: 32145466
Chaos Solitons Fractals. 2020 Nov;140:110173
pubmed: 32834653
Swiss Med Wkly. 2020 May 30;150:w20295
pubmed: 32472939
PLoS One. 2015 Jul 15;10(7):e0133203
pubmed: 26176549
Swiss Med Wkly. 2020 Mar 16;150:w20224
pubmed: 32176808
Chaos. 2020 Jul;30(7):071101
pubmed: 32752627
Swiss Med Wkly. 2020 May 04;150:w20277
pubmed: 32374886
Chaos Solitons Fractals. 2020 Oct;139:110049
pubmed: 32834603
Swiss Med Wkly. 2020 Mar 19;150:w20225
pubmed: 32191813
Health Commun. 2021 Jan;36(1):98-108
pubmed: 33198528
Am J Respir Crit Care Med. 2020 May 1;201(9):1150-1152
pubmed: 32200654
PLoS Med. 2008 Mar 25;5(3):e74
pubmed: 18366252

Auteurs

Janne Estill (J)

Institute of Global Health, University of Geneva, Geneva, GE, 1202, Switzerland.
Institute of Mathematical Statistics and Actuarial Science, University of Bern, Bern, BE, 3012, Switzerland.

Plamenna Venkova-Marchevska (P)

Institute of Global Health, University of Geneva, Geneva, GE, 1202, Switzerland.

Maroussia Roelens (M)

Institute of Global Health, University of Geneva, Geneva, GE, 1202, Switzerland.

Erol Orel (E)

Institute of Global Health, University of Geneva, Geneva, GE, 1202, Switzerland.

Alexander Temerev (A)

Institute of Global Health, University of Geneva, Geneva, GE, 1202, Switzerland.

Antoine Flahault (A)

Institute of Global Health, University of Geneva, Geneva, GE, 1202, Switzerland.

Olivia Keiser (O)

Institute of Global Health, University of Geneva, Geneva, GE, 1202, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH